Last $105.88 USD
Change Today +1.16 / 1.11%
Volume 6.1M
JNJ On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
Sao Paulo
Bogota
As of 4:15 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

johnson & johnson (JNJ) Key Developments

Johnson & Johnson Seeks Acquisitions

Johnson & Johnson (NYSE:JNJ) is looking for acquisitions. Dominic Caruso, Chief Financial Officer of Johnson & Johnson said, having an acquisition return lower than the cost of capital seems like a very inefficient use of capital and rather than do one major acquisition where you have that level of risk we could certainly do 10 acquisitions of smaller sizes that give you that kind of buffer of that risk or give you a portfolio approach to the acquisition that kind of gives you a sense that some will work better than others, of course, therefore you have a higher degree of probability that you will return - get a return higher than your cost of capital.

Johnson & Johnson Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-10-2014 09:45 AM

Johnson & Johnson Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-10-2014 09:45 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Dominic J. Caruso, Chief Financial Officer, Vice President of Finance and Member of Executive Committee.

Johnson & Johnson Reportedly Plans To Shed Cordis

Johnson & Johnson (NYSE:JNJ) reportedly intends to dispose of its medical devices unit Cordis Corporation. A potential sale which is currently in its early stages could bring between $1.5 billion and $2 billion. The unit was expected to attract bids from private equity players and rival healthcare companies.

Johnson & Johnson Reportedly Seeks Buyer for Cordis Medical-Device Unit

Johnson & Johnson (NYSE:JNJ) reportedly plans to seek a buyer for Cordis Medical-Device Unit. As reported, the business, which could fetch between $1.5 billion and $2 billion, is expected to attract interest from private-equity firms and other health-care companies.

Johnson & Johnson Announces Dividend for the Third Quarter of 2014, Payable on September 9, 2014

NEW Johnson & Johnson announced that its Board of Directors has declared a cash dividend for the third quarter of 2014 of $0.70 per share on the company's common stock. The dividend is payable on September 9, 2014 to shareholders of record at the close of business on August 26, 2014. The ex-dividend date is August 22, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $105.88 USD +1.16

JNJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Intel Corp $34.93 USD +0.39
International Business Machines Corp $192.96 USD +1.15
Pfizer Inc $30.05 USD +0.13
Roche Holding AG SFr.277.50 CHF +1.70
Procter & Gamble Co/The $84.08 USD +0.21
View Industry Companies
 

Industry Analysis

JNJ

Industry Average

Valuation JNJ Industry Range
Price/Earnings 19.4x
Price/Sales 4.0x
Price/Book 3.8x
Price/Cash Flow 19.0x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.